SEC Form 4 · accession 0001203311-16-000181
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaughn B Himes
Officer — Chief Technical Officer
Period of report
Dec 12, 2016
Accepted (ET)
Dec 14, 2016 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2016 | M | 3,831 | $26.10 | A | 139,210 | D | |
| Common StockF1 | Dec 12, 2016 | M | 6,468 | $15.46 | A | 145,678 | D | |
| Common StockF1 | Dec 12, 2016 | M | 5,333 | $12.00 | A | 151,011 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $12.00 | Dec 12, 2016 | M | 5,333 | D | — | Aug 27, 2020 | Common Stock | 5,333 | 0 | D |
| Incentive Stock Option (right to buy)F3 | $15.46 | Dec 12, 2016 | M | 6,468 | D | — | Aug 24, 2021 | Common Stock | 6,468 | 0 | D |
| Incentive Stock Option (right to buy)F4 | $26.10 | Dec 12, 2016 | M | 3,831 | D | — | Aug 20, 2022 | Common Stock | 3,831 | 0 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Shares vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14.
- F3Shares vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15.
- F4Shares vested at a rate of 25% on 8/20/13 and monthly thereafter until all the shares were fully vested on 8/20/16.